NCT04209374

Brief Summary

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty with a SYMBOL CUP DM HA hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of that implant at two-year follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2015

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2019

Completed
Last Updated

December 30, 2019

Status Verified

December 1, 2019

Enrollment Period

1.5 years

First QC Date

December 20, 2019

Last Update Submit

December 25, 2019

Conditions

Keywords

primary total hip arthroplastyhemispherical dual-mobility acetabular cupsafetyefficacyimplant survivalprosthetic dislocationHarris hip score HHS

Outcome Measures

Primary Outcomes (1)

  • Implant survival: Ratio of the number of participants alive with the complete index hip prosthesis in position at 2-year follow-up, over their initial numberprosthesis in position at 2-year follow-up, over their initial number.

    This is the ratio of the number of participants who are alive with the complete index hip prosthesis in position at a given follow-up time (numerator) over the initial number of those participants from the date they received the index hip prosthesis (denominator). The cumulative ratio is recalculated at each event using the Kaplan-Meier method from the date of each participant index operation through the date of each participant's death or prosthetic removal surgery or loss-to-follow-up or last assessment alive with the hip prosthesis in place. The longest duration between the index operation and the final assessment is 2 years.

    2 years as of index operation

Secondary Outcomes (5)

  • Number of patients with one or several post-operative adverse events and count of each Serious adverse event and aggregate count of adverse events

    2 years as of index operation

  • Harris Hip Score (HHS) at baseline and 1-year follow-up

    1 year as of index operation

  • The modified Harris Hip Score (modified HHS) at baseline, 1-year and 2-year follow-up

    2 years as of index operation

  • Devane classification at baseline, 1-year and 2-year follow-up.

    2 years as of index operation

  • Charnley classification at baseline, 1-year and 2-year follow-up.

    2 years as of index operation

Study Arms (1)

HMB-DMR-HA

Primary total hip arthroplasty with hemispherical dual-mobility acetabular cup

Device: THA with SYMBOL CUP DM HA

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Exhaustive recruitment of patients meeting inclusion and exclusion criteria

You may qualify if:

  • All patients with total hip implant using hemispheric dual-mobility SYMBOL CUP DM HA
  • Operation performed by the primary investigator
  • Delay between index operation and March 1 2018 has reached 2 years

You may not qualify if:

  • patient refusal to participate in the study
  • minors (age \< 18 years)
  • patients under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lyon Ortho Clinic - Clinique de la Sauvegarde

Lyon, 69009, France

Location

Study Officials

  • Nicolas Bonin, M.D.

    Lyon Ortho Clinic - Clinique de la Sauvegarde

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2019

First Posted

December 24, 2019

Study Start

July 3, 2014

Primary Completion

December 17, 2015

Study Completion

March 1, 2018

Last Updated

December 30, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations